top of page
The Human Variable
Search


Bioadaptive Systems Therapeutics™ (BST): Engineering Remission Through Terrain Logic
Bioadaptive Systems Therapeutics™ (BST) is a new discipline of medicine that engineers remission by recalibrating fragile biological systems across immune, autonomic, mitochondrial, connective, hormonal, and environmental domains. Unlike traditional medicine, which classifies disease onset and treats within rigid silos, BST is phase-aware, terrain-first, and subtype-specific.
Sep 29


Why Drug Approval for ME/CFS Was Always a Setup
Clinical trials for ME/CFS have consistently failed not because therapies were inherently ineffective, but because the system was never built for conditions like ME/CFS and related IACCs. FDA gold-standard trial design assumes predictable progression, uniform subtypes, and tolerance for interventions — none of which apply to ME/CFS The CYNAERA Thesis asserts that repurposed drugs can work for ME/CFS if trials account for post-exertional malaise (PEM),(MCAS), and POTS
Aug 26


A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions - Lite
A Nobel-scale leap, built outside the system. This isn’t just another CRISPR project. CYNAERA’s AI-powered gene editing platform was designed by a patient, for patients—modeling remission across millions of synthetic profiles to restore immune stability in infection-associated chronic conditions like Long COVID, ME/CFS, and MCAS.
It cuts years off clinical trial timelines. It eliminates $5–10 million in early development costs. It’s scalable and ethical globally. AI meets bio
May 8


A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions
A Nobel-scale leap, built outside the system. This isn’t just another CRISPR project. CYNAERA’s AI-powered gene editing platform was designed by a patient, for patients—modeling remission across millions of synthetic profiles to restore immune stability in infection-associated chronic conditions like Long COVID, ME/CFS, and MCAS.
It cuts years off clinical trial timelines. It eliminates $5–10 million in early development costs. It’s scalable and ethical globally. AI meets bio
May 7


AI That Sees the Whole Picture: Tracking Symptoms and Consequences
As AI technology continues to revolutionize healthcare, one crucial aspect that cannot be overlooked is data privacy and security.
Apr 11


The Hidden Cost of Default Logic: Why Most Systems Fail Before They Start
Default Logic is the baked-in code, policy, or logic that treats outdated context as static truth. A wrong assumption that costs real money.
Apr 8
bottom of page
